ARCHIVES

Master’s Program In Nurse Oncology Kept Alive; Final Decisions In February

This article is from The Cancer Letter archive.

Vol. 03 No. 42 | October 21, 1977

Download PDF Visit The Full Archive

Related Articles

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

March 5, 1999

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

March Dedicated To Colorectal Cancer Awareness; New Advocacy Group.

March 10, 2000

In Brief: Thomas Jordan Promoted At Bristol-Myers, Markison To Succeed Him In Oncology Div.

February 28, 1992

In Brief: Lepovetsky Heads New NCI Office Of Technology Development; Temporary Now, Maybe Permanent

November 27, 1987

Trials Approved by NCI CTEP For The Month of February

February 24, 2012